Preparation and Characterization of Silica Coated Magnetic Cu Based MOF as a Nanocarrier for Gradual Release of the Capecitabine Anticancer Drug

Subject Areas : Journal of Nanoanalysis

Azar  Asgari Pari ¹ (Department of Chemistry, Yadegar-e Imam Khomeini(RAH) Shahr-e-Rey Branch, Islamic Azad University, Tehran, Iran)
Susan  Samadi ² (Department of Chemistry, Yadegar-e Imam Khomeini(RAH) Shahr-e-Rey Branch, Islamic Azad University, Tehran, Iran)
Mohammad Reza__Allahgholi__Ghasri  Mohammad Reza__Allahgholi__Ghasri ³ (Department of Chemistry, Yadegar-e Imam Khomeini(RAH) Shahr-e-Rey Branch, Islamic Azad University, Tehran, Iran)
Maryam  Torbati ⁴ (Department of Chemistry, College of Basic Science, Yadegar-e-Imam Khomeini (RAH) Shahr-e-Rey Branch, Islamic Azad University, Tehran, 3319118651 ,Iran)
Mohammad  Yousefi ⁵ (Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran)

Received: 2022-01-20 Accepted : 2024-05-26 Published : 2024-05-14

Keywords: Metal&ndash, organic frameworks, Magneic nanoparticles, Drug delivery, Release, Capecitabine,

Abstract :

This study developed a novel silica-coated magnetic nanoparticle (Fe3O4@SiO2@Cu BTC) based on a metal-organic framework (MOF) for targeted anticancer medication delivery. Using a co-precipitation method, the Fe3O4@SiO2 core was coated with Cu(OH)2 shell, which was then converted to CuBTC in a hydroethanolic mixture. Finally, a post-synthetic approach was used to manufacture a 3-(mercaptopropyl) trimethoxysilane functionalized Fe3O4@SiO2@Cu BTC nanocomposite. The resulting material is characterized using SEM-EDX, TEM, VSM, XRD, TGA, BET, UV–Vis, and FTIR techniques. TEM and SEM micrographs confirmed the core-shell structure. The resulting nanocomposite has high thermal stability, according to TGA findings. Because of their great biocompatibility and drug loading capability, coated Fe3O4@SiO2@Cu BTC nanoparticles might be perfect for drug delivery. Capecitabine (CAP), an anticancer medication, was successfully dispersed through MOF pores. The acquired data revealed that 91 percent of the CAP was adsorbed on the constructed framework, and that the release of capecitabine in PBS buffer solution (pH 5.7) at 37 °C took up to 60 hours to complete. The findings show that nano-sized MOFs-based magnetic NPs with high drug loading and acceptable biocompatibility are viable options for targeted drug delivery.

References:

REFERENCES
[1] Mateo J, Steuten L, Aftimos P, André F, Davies M, Garralda E, Geissler J, Husereau D, Martinez-Lopez I, Normanno N, Reis-Filho JS. Delivering precision oncology to patients with cancer. Nature Medicine. 2022;28(4):658-65.
[2] Zeng Y, Zhang C, Du D, Li Y, Sun L, Han Y, He X, Dai J, Shi L. Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy. Acta Biomaterialia. 2022;145:43-51.
[3] Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chemical reviews. 2015;115(4):1990-2042.
[4] Deng C, Jiang Y, Cheng R, Meng F, Zhong Z. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects. Nano Today. 2012;7(5):467-80.
[5] Cheung C, Al-Jamal WT. Liposomes-based nanoparticles for cancer therapy and bioimaging, in Nanooncology. 2018; Springer:51-87.
[6] Molina M, Asadian-Birjand M, Balach J, Bergueiro J, Miceli E, Calderón M. Stimuli-responsive nanogel composites and their application in nanomedicine. Chemical Society Reviews. 2015;44(17):6161-86.
[7] He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. Journal of Materials Chemistry. 2011;21(16):5845-55.
[8] Saghi M, Shokri A, Arastehnodeh A, Khazaeinejad M, Nozari A The photo degradation of methyl red in aqueous solutions by α-Fe2O3/SiO2 nano photocatalyst. Journal of Nanoanalysis. 2018;5(3):163-70.
[9] Fu F, Wu Y, Zhu J, Wen S, Shen M, Shi X. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer. ACS Applied Materials & Interfaces. 2014;6(18):16416-25.
[10] Guo Y, Chu M, Tan S, Zhao S, Liu H, Otieno BO, Yang X, Xu C, Zhang Z. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Molecular pharmaceutics. 2014;11(1):59-70.
[11] Rostami M, Mazaheri H, Hassani Joshaghani A, Shokri A. Using experimental design to optimize the photo-degradation of P-nitro toluene by Nano-TiO2 in synthetic wastewater. International Journal of Engineering. 2019;32(8):1074-81.
[12] Shokri A. Using Mn based on lightweight expanded clay aggregate (LECA) as an original catalyst for the removal of NO2 pollutant in aqueous environment. Surfaces and Interfaces. 2020;21:100705.
[13] Rostami M, Hassani Joshaghani A, Mazaheri H, Shokri A. Photo-degradation of P-Nitro Toluene Using Modified Bentonite Based Nano-TiO2 Photocatalyst in Aqueous Solution. International Journal of Engineering. 2021;34(4):756-62.
[14] Shokri A. Using NiFe2O4 as a nano photocatalyst for degradation of polyvinyl alcohol in synthetic wastewater. Environmental Challenges. 2021;5:100332.
[15] Dhavale RP, Dhavale RP, Sahoo SC, Kollu P, Jadhav SU, Patil PS, Dongale TD, Chougale AD, Patil PB. Chitosan coated magnetic nanoparticles as carriers of anticancer drug Telmisartan: pH-responsive controlled drug release and cytotoxicity studies. Journal of Physics and Chemistry of Solids. 2021;148:109749.
[16] Chowdhuri AR, Bhattacharya D, Sahu SK. Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agent. Dalton Transactions. 2016;45(7):2963-73.
[17] Yousefi M, Safari M, Torbati MB, Kazemiha VM, Sanati H, Amanzadeh A. New mononuclear diorganotin (IV) dithiocarboxylates: synthesis, characterization and study of their cytotoxic activities. Applied Organometallic Chemistry. 2012;26(8):438-44.
[18] Bikhof Torbati M, Ebrahimian M, Yousefi M, Shaabanzadeh M. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line. Artificial cells, Nanomedicine, and Biotechnology. 2017;45(3):568-73.
[19] Liu J, Huang J, Zhang L, Lei J. Multifunctional metal–organic framework heterostructures for enhanced cancer therapy. Chemical Society Reviews. 2021;50(2):1188-218.
[20] Wo R, Li QL, Zhu C, Zhang Y, Qiao GF, Lei KY, Du P, Jiang W. Preparation and characterization of functionalized metal–organic frameworks with core/shell magnetic particles (Fe3O4@ SiO2@ MOFs) for removal of Congo red and methylene blue from water solution. Journal of Chemical & Engineering Data. 2019;64(6):2455-63.
[21] Boukoussa B, Abidallah F, Abid Z, Talha Z, Taybi N, El Hadj HS. Synthesis of polypyrrole/Fe-kanemite nanocomposite through in situ polymerization: effect of iron exchange, acid treatment, and CO2 adsorption properties. Journal of Materials Science. 2017;52(5):2460-72.
[22] Kaur R, Vellingiri K, Kim K-H, Paul A, Deep A. Efficient photocatalytic degradation of rhodamine 6G with a quantum dot-metal organic framework nanocomposite. Chemosphere. 2016;154:620-7.
[23] Qi Z, Chen Y. Charge-transfer-based terbium MOF nanoparticles as fluorescent pH sensor for extreme acidity. Biosensors and Bioelectronics. 2017;87:236-41.
[24] Ma R, Yang P, Ma Y, Bian F. Facile Synthesis of Magnetic Hierarchical Core–Shell Structured Fe3O4@ PDA‐Pd@ MOF Nanocomposites: Highly Integrated Multifunctional Catalysts. ChemCatChem. 2018;10(6):1446-54.
[25] Ricco R, Malfatti L, Takahashi M, Hill AJ, Falcaro P. Applications of magnetic metal–organic framework composites. Journal of Materials Chemistry A. 2013;1(42):13033-45.
[26] Maya F, Cabello CP, Frizzarin RM, Estela JM, Palomino GT, Cerdà V. Magnetic solid-phase extraction using metal-organic frameworks (MOFs) and their derived carbons. TrAC Trends in Analytical Chemistry. 2017;90:142-52.
[27] Zhao X, Liu S, Tang Z, Niu H, Cai Y, Meng W. Synthesis of magnetic metal-organic framework (MOF) for efficient removal of organic dyes from water. Scientific Reports. 2015;5(1):1-10.
[28] Simon-Yarza T, Giménez-Marqués M, Mrimi R, Mielcarek A, Gref R, Horcajada P. A smart metal–organic framework nanomaterial for lung targeting. Angewandte Chemie. 2017;129(49):15771-75.
[29] Osterrieth JW, Fairen‐Jimenez D. Metal–organic framework composites for theragnostics and drug delivery applications. Biotechnology Journal. 2021;16(2):2000005.
[30] Wang X, Liang T, Zheng Z, Guo R, Zhang Z. MOF-silica hybrid derived high performance K-Cu# SiO2 catalyst for furfural valorization: the functional role of potassium acetate (KAc) in hybridization and copper electronic state. Applied Catalysis A: General. 2022:118603.
[31] Li L, Liu XL, Gao M, Hong W, Liu GZ, Fan L. The adsorption on magnetic hybrid Fe3O4/HKUST-1/GO of methylene blue from water solution. Journal of Materials Chemistry A. 2014;2(6):1795-801.
[32] Sanchez-Sala M, Vallcorba O, Domingo C, Ayllón JA. Acetic acid as a solvent for the synthesis of metal–organic frameworks based on trimesic acid. Polyhedron. 2019;170:458-62.
[33] Anand U, Dey A, Chandel AK, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, Dhanjal JK. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases (2022), (in press).
[34] Wu Yn, Zhou M, Li S, Li Z, Li J, Wu B. Magnetic metal–organic frameworks: γ‐Fe2O3@ MOFs via confined in situ pyrolysis method for drug delivery. Small. 2014;10(14):2927-36.
[35] Silvestre ME, Franzreb M, Weidler PG, Shekhah O, Wöll C. Magnetic Cores with Porous Coatings: Growth of Metal‐Organic Frameworks on Particles Using Liquid Phase Epitaxy. Advanced Functional Materials. 2013;23(9):1210-13.
[36] Javanbakht S, Nezhad-Mokhtari P, Shaabani A, Arsalani N, Ghorbani M. Incorporating Cu-based metal-organic framework/drug nanohybrids into gelatin microsphere for ibuprofen oral delivery. Materials Science and Engineering: C. 2019;96:302-9.
[37] Hou L, Liu Y, Liu W, Balash M, Zhang H. In situ triggering antitumor efficacy of alcohol-abuse drug disulfiram through Cu-based metal-organic framework nanoparticles. Acta Pharmaceutica Sinica B. 2021;11(7):2016-30.
[38] Chen J, Liu J, Hu Y, Tian Z, Zhu Y. Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release. Science and technology of advanced materials. 2019;20(1):1043-54.
[39] Morovati A, Panahi HA, Yazdani F. Grafting of allylimidazole and n-vinylcaprolactam as a thermosensitive polymer onto magnetic nano-particles for the extraction and determination of celecoxib in biological samples. International Journal of Pharmaceutics. 2016;513(1-2):62-7.
[40] Huang L, He M, Chen B, Hu B. A designable magnetic MOF composite and facile coordination-based post-synthetic strategy for the enhanced removal of Hg 2+ from water. Journal of Materials Chemistry A. 2015;3(21):11587-95.
[41] Majano G, Pérez-Ramírez J. Scalable room‐temperature conversion of copper (II) hydroxide into HKUST‐1 (Cu3(btc)2). Advanced Materials. 2013;25(7):1052-7.
[42] Lajevardi A, Sadr MH, Yaraki MT, Badiei A, Armaghan M. A pH-responsive and magnetic Fe3O4@ silica@ MIL-100 (Fe)/β-CD nanocomposite as a drug nanocarrier: loading and release study of cephalexin. New Journal of Chemistry. 2018;42(12):9690-701.
[43] Kavousi F, Goodarzi M, Ghanbari D, Hedayati K. Synthesis and characterization of a magnetic polymer nanocomposite for the release of metoprolol and aspirin. Journal of Molecular Structure. 2019;1183:324-30.
[44] Chowdhury P, Bikkina C, Meister D, Dreisbach F, Gumma S. Comparison of adsorption isotherms on Cu-BTC metal organic frameworks synthesized from different routes. Microporous and Mesoporous Materials. 2009;117(1-2):406-413.